Henna Pehkonen
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Biological evaluation of a glucose-based boron carrier as a potential agent for boron neutron capture therapy.
Journal: International journal of cancer
Published: January 14, 2025
Asymmetric Synthesis and Biological Evaluation of Both Enantiomers of 5- and 6-Boronotryptophan as Potential Boron Delivery Agents for Boron Neutron Capture Therapy.
Journal: ACS medicinal chemistry letters
Published: June 26, 2024
Liprin-α1 contributes to oncogenic MAPK signaling by counteracting ERK activity.
Journal: Molecular oncology
Published: July 05, 2023
Liprin-α1 Expression in Tumor-Infiltrating Lymphocytes Associates with Improved Survival in Patients with HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Journal: Head and neck pathology
Published: March 31, 2023
Liprin-α1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.
Journal: Cell communication and signaling : CCS
Published: April 09, 2018
Liprin-α1 is a regulator of vimentin intermediate filament network in the cancer cell adhesion machinery.
Journal: Scientific reports
Published: December 18, 2015
Identification of several potential chromatin binding sites of HOXB7 and its downstream target genes in breast cancer.
Journal: International journal of cancer
Published: November 04, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026